Xvivo is scheduled to release its fourth-quarter earnings results tomorrow before the stock market opens. Following the release, the company will host a telephone conference at 2:00 p.m. CET. While comps are challenging, we expect to see continued strong growth, driven by increasing sales related to warm perfusion.